Agenus (Formerly known as Antigenics Inc. - Lexington, MA) (AGEN) Reports Third Quarter 2012 Financial Results  
10/25/2012 9:22:41 AM

LEXINGTON, Mass., Oct. 25, 2012 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a biotechnology company working to develop novel immunology based treatments for cancers and infectious diseases, today announced its financial results and business highlights for the third quarter ended September 30, 2012.